Rational Drug Design pp 185-195

Part of the Methods in Molecular Biology book series (MIMB, volume 928)

Utilizing AntagomiR (Antisense microRNA) to Knock Down microRNA in Murine Bone Marrow Cells

Protocol

Abstract

MicroRNAs (miRNAs) are highly conserved small RNAs which regulate gene expression primarily through base pairing to the 3′ untranslated region of target messenger RNA (mRNA), leading to mRNA degradation or translation inhibition depending on the complementarity between the miRNA and target mRNA. Single miRNA regulates multiple target mRNA. miRNAs have been shown to regulate gene expression in the hematopoietic stem cells, as well as at key decision points for various lineages. However, aberrant expression of miRNAs has been documented in cancer and disease models. Rigorous dissection of miRNA pathways and biology requires facile loss of function modeling. This chapter describes detailed protocol for knockdown miRNA-21 which is involved in myelopoiesis using antagomiRs in primary murine bone marrow stem/progenitor cells.

Key words

microRNA Antagomir Murine bone marrow cells Drug delivery 

References

  1. 1.
    Nakasa T, Nagata Y, Yamasaki K, Ochi M (2011) A mini-review: MicroRNA in Arthritis. Physiol Genomics 43(10):566–70PubMedCrossRefGoogle Scholar
  2. 2.
    Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20PubMedCrossRefGoogle Scholar
  3. 3.
    Zhdanov VP (2009) Conditions of appreciable influence of microRNA on a large number of target mRNAs. Mol Biosyst 5:638–43PubMedCrossRefGoogle Scholar
  4. 4.
    Shah AA, Meese E, Blin N (2010) Profiling of regulatory microRNA transcriptomes in various biological processes: a review. J Appl Genet 51:501–7PubMedCrossRefGoogle Scholar
  5. 5.
    Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–6PubMedCrossRefGoogle Scholar
  6. 6.
    Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–66PubMedCrossRefGoogle Scholar
  7. 7.
    Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004PubMedCrossRefGoogle Scholar
  8. 8.
    Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–6PubMedCrossRefGoogle Scholar
  9. 9.
    Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, Weidhaas JB, Bader AG, Slack FJ (2011) Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice. Mol Ther 19(6):1116–22PubMedCrossRefGoogle Scholar
  10. 10.
    Todesco M, Rubio-Somoza I, Paz-Ares J, Weigel D (2010) A collection of target mimics for comprehensive analysis of microRNA function in Arabidopsis thaliana. PLoS Genet 6:e1001031PubMedCrossRefGoogle Scholar
  11. 11.
    Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, Ponzoni M, Naldini L (2009) Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6:63–6PubMedCrossRefGoogle Scholar
  12. 12.
    Scherr M, Venturini L, Eder M (2010) Lentiviral vector-mediated expression of pre-miRNAs and antagomiRs. Methods Mol Biol 614:175–85PubMedCrossRefGoogle Scholar
  13. 13.
    Mattes J, Yang M, Foster PS (2007) Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? Am J Respir Cell Mol Biol 36:8–12PubMedCrossRefGoogle Scholar
  14. 14.
    Griffiths-Jones S (2006) miRBase: the microRNA sequence database. Methods Mol Biol 342:129–38PubMedGoogle Scholar
  15. 15.
    Cooper SR, Taylor JK, Miraglia LJ, Dean NM (1999) Pharmacology of antisense oligonucleotide inhibitors of protein expression. Pharmacol Ther 82:427–35PubMedCrossRefGoogle Scholar
  16. 16.
    Velu CS, Baktula AM, Grimes HL (2009) Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 113:4720–8PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Immunobiology DivisionCincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations